| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCD1
|
ATP-binding cassette, sub-family D (ALD), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABCG5
|
ATP-binding cassette, sub-family G (WHITE), member 5
|
|
ABCG8
|
ATP-binding cassette, sub-family G (WHITE), member 8
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ABL2
|
ABL proto-oncogene 2, non-receptor tyrosine kinase
|
|
ACACA
|
acetyl-CoA carboxylase alpha
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACVR2A
|
activin A receptor, type IIA
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADORA3
|
adenosine A3 receptor
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AIM2
|
absent in melanoma 2
|
|
AIMP1
|
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1
|
|
AJAP1
|
adherens junctions associated protein 1
|
|
AJUBA
|
ajuba LIM protein
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
ALDH1A2
|
aldehyde dehydrogenase 1 family, member A2
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALDH3A1
|
aldehyde dehydrogenase 3 family, member A1
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
AMER1
|
APC membrane recruitment protein 1
|
|
ANAPC4
|
anaphase promoting complex subunit 4
|
|
ANAPC5
|
anaphase promoting complex subunit 5
|
|
ANGPTL4
|
angiopoietin-like 4
|
|
ANXA6
|
annexin A6
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APC
|
adenomatous polyposis coli
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APOBEC3B
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOC1
|
apolipoprotein C-I
|
|
APOC3
|
apolipoprotein C-III
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
APPL1
|
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1
|
|
AR
|
androgen receptor
|
|
AREG
|
amphiregulin
|
|
ARF1
|
ADP-ribosylation factor 1
|
|
ARF6
|
ADP-ribosylation factor 6
|
|
ARHGAP35
|
Rho GTPase activating protein 35
|
|
ARHGDIA
|
Rho GDP dissociation inhibitor (GDI) alpha
|
|
ARHGEF15
|
Rho guanine nucleotide exchange factor (GEF) 15
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
ARID2
|
AT rich interactive domain 2 (ARID, RFX-like)
|
|
ARMC5
|
armadillo repeat containing 5
|
|
ARNTL
|
aryl hydrocarbon receptor nuclear translocator-like
|
|
ASCL2
|
achaete-scute family bHLH transcription factor 2
|
|
ASH2L
|
ash2 (absent, small, or homeotic)-like (Drosophila)
|
|
ASIC1
|
acid sensing (proton gated) ion channel 1
|
|
ATF3
|
activating transcription factor 3
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
|
|
ATP2B1
|
ATPase, Ca++ transporting, plasma membrane 1
|
|
ATR
|
ATR serine/threonine kinase
|
|
AURKB
|
aurora kinase B
|
|
AXIN1
|
axin 1
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
B2M
|
beta-2-microglobulin
|
|
BAAT
|
bile acid CoA:amino acid N-acyltransferase
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BAX
|
BCL2-associated X protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BBS12
|
Bardet-Biedl syndrome 12
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCR
|
breakpoint cluster region
|
|
BECN1
|
beclin 1, autophagy related
|
|
BEX1
|
brain expressed, X-linked 1
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BIN1
|
bridging integrator 1
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRAP
|
BRCA1 associated protein
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRD4
|
bromodomain containing 4
|
|
BRINP1
|
bone morphogenetic protein/retinoic acid inducible neural-specific 1
|
|
BRSK1
|
BR serine/threonine kinase 1
|
|
BRSK2
|
BR serine/threonine kinase 2
|
|
BSN
|
bassoon presynaptic cytomatrix protein
|
|
BTG3
|
BTG family, member 3
|
|
BTG4
|
B-cell translocation gene 4
|
|
BUB1
|
BUB1 mitotic checkpoint serine/threonine kinase
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
C20ORF85
|
chromosome 20 open reading frame 85
|
|
C2ORF40
|
chromosome 2 open reading frame 40
|
|
C3
|
complement component 3
|
|
C5
|
complement component 5
|
|
CABLES1
|
Cdk5 and Abl enzyme substrate 1
|
|
CABP1
|
calcium binding protein 1
|
|
CABP4
|
calcium binding protein 4
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CACNA1F
|
calcium channel, voltage-dependent, L type, alpha 1F subunit
|
|
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit
|
|
CACNA2D1
|
calcium channel, voltage-dependent, alpha 2/delta subunit 1
|
|
CACNB1
|
calcium channel, voltage-dependent, beta 1 subunit
|
|
CACNB2
|
calcium channel, voltage-dependent, beta 2 subunit
|
|
CADM1
|
cell adhesion molecule 1
|
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta)
|
|
CALM2
|
calmodulin 2 (phosphorylase kinase, delta)
|
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CAPN1
|
calpain 1, (mu/I) large subunit
|
|
CARD11
|
caspase recruitment domain family, member 11
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP5
|
caspase 5, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCDC6
|
coiled-coil domain containing 6
|
|
CCL14
|
chemokine (C-C motif) ligand 14
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CD80
|
CD80 molecule
|
|
CD82
|
CD82 molecule
|
|
CD86
|
CD86 molecule
|
|
CD9
|
CD9 molecule
|
|
CDC20
|
cell division cycle 20
|
|
CDC25A
|
cell division cycle 25A
|
|
CDC25C
|
cell division cycle 25C
|
|
CDC42
|
cell division cycle 42
|
|
CDC73
|
cell division cycle 73
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast)
|
|
CDH13
|
cadherin 13
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDK7
|
cyclin-dependent kinase 7
|
|
CDKL5
|
cyclin-dependent kinase-like 5
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDKN2C
|
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
|
|
CDO1
|
cysteine dioxygenase type 1
|
|
CDON
|
cell adhesion associated, oncogene regulated
|
|
CDX1
|
caudal type homeobox 1
|
|
CDX2
|
caudal type homeobox 2
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CFH
|
complement factor H
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CFL2
|
cofilin 2 (muscle)
|
|
CHD5
|
chromodomain helicase DNA binding protein 5
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHFR
|
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase
|
|
CHM
|
choroideremia (Rab escort protein 1)
|
|
CHRNG
|
cholinergic receptor, nicotinic, gamma (muscle)
|
|
CHSY1
|
chondroitin sulfate synthase 1
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CKB
|
creatine kinase, brain
|
|
CMTM5
|
CKLF-like MARVEL transmembrane domain containing 5
|
|
CNKSR1
|
connector enhancer of kinase suppressor of Ras 1
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
COL4A3BP
|
collagen, type IV, alpha 3 (Goodpasture antigen) binding protein
|
|
COMT
|
catechol-O-methyltransferase
|
|
CP
|
ceruloplasmin (ferroxidase)
|
|
CPA6
|
carboxypeptidase A6
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CRH
|
corticotropin releasing hormone
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CSK
|
c-src tyrosine kinase
|
|
CSMD1
|
CUB and Sushi multiple domains 1
|
|
CSNK1A1
|
casein kinase 1, alpha 1
|
|
CST1
|
cystatin SN
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CTSB
|
cathepsin B
|
|
CTSK
|
cathepsin K
|
|
CTSL
|
cathepsin L
|
|
CUEDC2
|
CUE domain containing 2
|
|
CUL4A
|
cullin 4A
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP3A
|
cytochrome P450, family 3, subfamily A
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
DAB1
|
Dab, reelin signal transducer, homolog 1 (Drosophila)
|
|
DAB2IP
|
DAB2 interacting protein
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DAPK2
|
death-associated protein kinase 2
|
|
DCK
|
deoxycytidine kinase
|
|
DDB1
|
damage-specific DNA binding protein 1, 127kDa
|
|
DDIT4
|
DNA-damage-inducible transcript 4
|
|
DDX3X
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked
|
|
DEK
|
DEK proto-oncogene
|
|
DHRS4
|
dehydrogenase/reductase (SDR family) member 4
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DIRAS3
|
DIRAS family, GTP-binding RAS-like 3
|
|
DKC1
|
dyskeratosis congenita 1, dyskerin
|
|
DLC1
|
DLC1 Rho GTPase activating protein
|
|
DLEC1
|
deleted in lung and esophageal cancer 1
|
|
DLEU2
|
deleted in lymphocytic leukemia 2 (non-protein coding)
|
|
DMD
|
dystrophin
|
|
DNAJC15
|
DnaJ (Hsp40) homolog, subfamily C, member 15
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DPP10
|
dipeptidyl-peptidase 10 (non-functional)
|
|
DPP3
|
dipeptidyl-peptidase 3
|
|
DPP6
|
dipeptidyl-peptidase 6
|
|
DUOX1
|
dual oxidase 1
|
|
DUOX2
|
dual oxidase 2
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
DUSP12
|
dual specificity phosphatase 12
|
|
DUSP4
|
dual specificity phosphatase 4
|
|
DUSP6
|
dual specificity phosphatase 6
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F3
|
E2F transcription factor 3
|
|
E4F1
|
E4F transcription factor 1
|
|
ECT2
|
epithelial cell transforming 2
|
|
EDA
|
ectodysplasin A
|
|
EDN2
|
endothelin 2
|
|
EDN3
|
endothelin 3
|
|
EDNRB
|
endothelin receptor type B
|
|
EEF1E1
|
eukaryotic translation elongation factor 1 epsilon 1
|
|
EGFR
|
epidermal growth factor receptor
|
|
EHMT2
|
euchromatic histone-lysine N-methyltransferase 2
|
|
EI24
|
etoposide induced 2.4
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
|
EIF4A1
|
eukaryotic translation initiation factor 4A1
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
ENDOG
|
endonuclease G
|
|
EP300
|
E1A binding protein p300
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHA7
|
EPH receptor A7
|
|
EPHB2
|
EPH receptor B2
|
|
EPM2A
|
epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)
|
|
EPOR
|
erythropoietin receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
ETV4
|
ets variant 4
|
|
ETV6
|
ets variant 6
|
|
EXT1
|
exostosin glycosyltransferase 1
|
|
EXT2
|
exostosin glycosyltransferase 2
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F12
|
coagulation factor XII (Hageman factor)
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FAAH2
|
fatty acid amide hydrolase 2
|
|
FANCB
|
Fanconi anemia, complementation group B
|
|
FANCC
|
Fanconi anemia, complementation group C
|
|
FANCF
|
Fanconi anemia, complementation group F
|
|
FANCM
|
Fanconi anemia, complementation group M
|
|
FBP1
|
fructose-1,6-bisphosphatase 1
|
|
FBXO18
|
F-box protein, helicase, 18
|
|
FBXO32
|
F-box protein 32
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FH
|
fumarate hydratase
|
|
FHIT
|
fragile histidine triad
|
|
FLCN
|
folliculin
|
|
FLNA
|
filamin A, alpha
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXO4
|
forkhead box O4
|
|
FOXP3
|
forkhead box P3
|
|
FOXQ1
|
forkhead box Q1
|
|
FRMD7
|
FERM domain containing 7
|
|
FURIN
|
furin (paired basic amino acid cleaving enzyme)
|
|
FXYD1
|
FXYD domain containing ion transport regulator 1
|
|
FXYD3
|
FXYD domain containing ion transport regulator 3
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
GABARAP
|
GABA(A) receptor-associated protein
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GADD45B
|
growth arrest and DNA-damage-inducible, beta
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
|
GAS6
|
growth arrest-specific 6
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA4
|
GATA binding protein 4
|
|
GATA5
|
GATA binding protein 5
|
|
GCG
|
glucagon
|
|
GH1
|
growth hormone 1
|
|
GIT2
|
G protein-coupled receptor kinase interacting ArfGAP 2
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GMNN
|
geminin, DNA replication inhibitor
|
|
GNG7
|
guanine nucleotide binding protein (G protein), gamma 7
|
|
GNMT
|
glycine N-methyltransferase
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GPR33
|
G protein-coupled receptor 33 (gene/pseudogene)
|
|
GPX3
|
glutathione peroxidase 3
|
|
GRN
|
granulin
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
H2AFX
|
H2A histone family, member X
|
|
H2AFY
|
H2A histone family, member Y
|
|
HDAC2
|
histone deacetylase 2
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIC1
|
hypermethylated in cancer 1
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIF1AN
|
hypoxia inducible factor 1, alpha subunit inhibitor
|
|
HIPK1
|
homeodomain interacting protein kinase 1
|
|
HIPK2
|
homeodomain interacting protein kinase 2
|
|
HK1
|
hexokinase 1
|
|
HK2
|
hexokinase 2
|
|
HLTF
|
helicase-like transcription factor
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HNMT
|
histamine N-methyltransferase
|
|
HNRNPU
|
heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A)
|
|
HOXA2
|
homeobox A2
|
|
HOXA5
|
homeobox A5
|
|
HOXD3
|
homeobox D3
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRH4
|
histamine receptor H4
|
|
HRK
|
harakiri, BCL2 interacting protein
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSF2
|
heat shock transcription factor 2
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA9
|
heat shock 70kDa protein 9 (mortalin)
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
ID3
|
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein
|
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein
|
|
IDE
|
insulin-degrading enzyme
|
|
IFNG
|
interferon, gamma
|
|
IFT38
|
intraflagellar transport 38
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGFALS
|
insulin-like growth factor binding protein, acid labile subunit
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP7
|
insulin-like growth factor binding protein 7
|
|
IGFBPL1
|
insulin-like growth factor binding protein-like 1
|
|
IGHD
|
immunoglobulin heavy constant delta
|
|
IGK
|
immunoglobulin kappa locus
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL1B
|
interleukin 1, beta
|
|
IL32
|
interleukin 32
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL6
|
interleukin 6
|
|
ILK
|
integrin-linked kinase
|
|
ING1
|
inhibitor of growth family, member 1
|
|
ING4
|
inhibitor of growth family, member 4
|
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa
|
|
INS
|
insulin
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRF5
|
interferon regulatory factor 5
|
|
IRF7
|
interferon regulatory factor 7
|
|
IRF8
|
interferon regulatory factor 8
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB4
|
integrin, beta 4
|
|
JAG1
|
jagged 1
|
|
JAK2
|
Janus kinase 2
|
|
KCNA1
|
potassium channel, voltage gated shaker related subfamily A, member 1
|
|
KCNA3
|
potassium channel, voltage gated shaker related subfamily A, member 3
|
|
KCNA4
|
potassium channel, voltage gated shaker related subfamily A, member 4
|
|
KCNA5
|
potassium channel, voltage gated shaker related subfamily A, member 5
|
|
KCNC1
|
potassium channel, voltage gated Shaw related subfamily C, member 1
|
|
KCND2
|
potassium channel, voltage gated Shal related subfamily D, member 2
|
|
KCND3
|
potassium channel, voltage gated Shal related subfamily D, member 3
|
|
KCNE2
|
potassium channel, voltage gated subfamily E regulatory beta subunit 2
|
|
KCNE4
|
potassium channel, voltage gated subfamily E regulatory beta subunit 4
|
|
KCNH1
|
potassium channel, voltage gated eag related subfamily H, member 1
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNIP2
|
Kv channel interacting protein 2
|
|
KCNIP4
|
Kv channel interacting protein 4
|
|
KCNJ18
|
potassium channel, inwardly rectifying subfamily J, member 18
|
|
KCNK3
|
potassium channel, two pore domain subfamily K, member 3
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
KCNMB2
|
potassium channel subfamily M regulatory beta subunit 2
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNQ4
|
potassium channel, voltage gated KQT-like subfamily Q, member 4
|
|
KCNQ5
|
potassium channel, voltage gated KQT-like subfamily Q, member 5
|
|
KCTD11
|
potassium channel tetramerization domain containing 11
|
|
KDM5C
|
lysine (K)-specific demethylase 5C
|
|
KIAA1524
|
KIAA1524
|
|
KLF11
|
Kruppel-like factor 11
|
|
KLF2
|
Kruppel-like factor 2
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLF6
|
Kruppel-like factor 6
|
|
KLK10
|
kallikrein-related peptidase 10
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LARS2
|
leucyl-tRNA synthetase 2, mitochondrial
|
|
LATS2
|
large tumor suppressor kinase 2
|
|
LECT2
|
leukocyte cell-derived chemotaxin 2
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LIFR
|
leukemia inhibitory factor receptor alpha
|
|
LIMD1
|
LIM domains containing 1
|
|
LIMK1
|
LIM domain kinase 1
|
|
LIN28B
|
lin-28 homolog B (C. elegans)
|
|
LIN9
|
lin-9 DREAM MuvB core complex component
|
|
LLGL1
|
lethal giant larvae homolog 1 (Drosophila)
|
|
LMAN1
|
lectin, mannose-binding, 1
|
|
LMNA
|
lamin A/C
|
|
LPL
|
lipoprotein lipase
|
|
LRP1B
|
low density lipoprotein receptor-related protein 1B
|
|
LRP8
|
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor
|
|
LRRC4
|
leucine rich repeat containing 4
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTF
|
lactotransferrin
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAD1L1
|
MAD1 mitotic arrest deficient-like 1 (yeast)
|
|
MAD2L1
|
MAD2 mitotic arrest deficient-like 1 (yeast)
|
|
MAD2L1BP
|
MAD2L1 binding protein
|
|
MAGI1
|
membrane associated guanylate kinase, WW and PDZ domain containing 1
|
|
MAL
|
mal, T-cell differentiation protein
|
|
MALT1
|
MALT1 paracaspase
|
|
MAOA
|
monoamine oxidase A
|
|
MAOB
|
monoamine oxidase B
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MAPKAPK5
|
mitogen-activated protein kinase-activated protein kinase 5
|
|
MAPT
|
microtubule-associated protein tau
|
|
MAVS
|
mitochondrial antiviral signaling protein
|
|
MBD1
|
methyl-CpG binding domain protein 1
|
|
MBNL1
|
muscleblind-like splicing regulator 1
|
|
MBNL2
|
muscleblind-like splicing regulator 2
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCM4
|
minichromosome maintenance complex component 4
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MEPE
|
matrix extracellular phosphoglycoprotein
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGA
|
MGA, MAX dimerization protein
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MINA
|
MYC induced nuclear antigen
|
|
MIR10B
|
microRNA 10b
|
|
MIR129-2
|
microRNA 129-2
|
|
MIR143
|
microRNA 143
|
|
MIR145
|
microRNA 145
|
|
MIR146B
|
microRNA 146b
|
|
MIR17
|
microRNA 17
|
|
MIR203A
|
microRNA 203a
|
|
MIR21
|
microRNA 21
|
|
MIR34A
|
microRNA 34a
|
|
MIR34B
|
microRNA 34b
|
|
MIR34C
|
microRNA 34c
|
|
MIR421
|
microRNA 421
|
|
MIR7-1
|
microRNA 7-1
|
|
MLH1
|
mutL homolog 1
|
|
MMACHC
|
methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP16
|
matrix metallopeptidase 16 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MOXD2P
|
monooxygenase, DBH-like 2, pseudogene
|
|
MPO
|
myeloperoxidase
|
|
MPP3
|
membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3)
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MT1E
|
metallothionein 1E
|
|
MTAP
|
methylthioadenosine phosphorylase
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTM1
|
myotubularin 1
|
|
MTNR1A
|
melatonin receptor 1A
|
|
MTNR1B
|
melatonin receptor 1B
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUTYH
|
mutY homolog
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYEOV
|
myeloma overexpressed
|
|
MYO1A
|
myosin IA
|
|
MYO5B
|
myosin VB
|
|
MYOCD
|
myocardin
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
|
NBN
|
nibrin
|
|
NDN
|
necdin, melanoma antigen (MAGE) family member
|
|
NDRG2
|
NDRG family member 2
|
|
NDST1
|
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1
|
|
NEDD9
|
neural precursor cell expressed, developmentally down-regulated 9
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NLRC4
|
NLR family, CARD domain containing 4
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NMU
|
neuromedin U
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH3
|
notch 3
|
|
NOX5
|
NADPH oxidase, EF-hand calcium binding domain 5
|
|
NPR2
|
natriuretic peptide receptor 2
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NUTF2
|
nuclear transport factor 2
|
|
NUTM1
|
NUT midline carcinoma, family member 1
|
|
OFD1
|
oral-facial-digital syndrome 1
|
|
OGDHL
|
oxoglutarate dehydrogenase-like
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OPCML
|
opioid binding protein/cell adhesion molecule-like
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
ORAI2
|
ORAI calcium release-activated calcium modulator 2
|
|
ORAI3
|
ORAI calcium release-activated calcium modulator 3
|
|
OSCP1
|
organic solute carrier partner 1
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
PAG1
|
phosphoprotein membrane anchor with glycosphingolipid microdomains 1
|
|
PALB2
|
partner and localizer of BRCA2
|
|
PAM
|
peptidylglycine alpha-amidating monooxygenase
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARK7
|
parkinson protein 7
|
|
PAX5
|
paired box 5
|
|
PBRM1
|
polybromo 1
|
|
PBX1
|
pre-B-cell leukemia homeobox 1
|
|
PCDH8
|
protocadherin 8
|
|
PCGF2
|
polycomb group ring finger 2
|
|
PCK1
|
phosphoenolpyruvate carboxykinase 1 (soluble)
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDK2
|
pyruvate dehydrogenase kinase, isozyme 2
|
|
PDK4
|
pyruvate dehydrogenase kinase, isozyme 4
|
|
PDLIM4
|
PDZ and LIM domain 4
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PENK
|
proenkephalin
|
|
PER3
|
period circadian clock 3
|
|
PFN1
|
profilin 1
|
|
PGAM4
|
phosphoglycerate mutase family member 4
|
|
PHLPP1
|
PH domain and leucine rich repeat protein phosphatase 1
|
|
PHPT1
|
phosphohistidine phosphatase 1
|
|
PIEZO1
|
piezo-type mechanosensitive ion channel component 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIKFYVE
|
phosphoinositide kinase, FYVE finger containing
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PKD2L1
|
polycystic kidney disease 2-like 1
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCB3
|
phospholipase C, beta 3 (phosphatidylinositol-specific)
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLD2
|
phospholipase D2
|
|
PLG
|
plasminogen
|
|
PLTP
|
phospholipid transfer protein
|
|
PLXNB3
|
plexin B3
|
|
PLXND1
|
plexin D1
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
|
POLI
|
polymerase (DNA directed) iota
|
|
POLL
|
polymerase (DNA directed), lambda
|
|
POMC
|
proopiomelanocortin
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPID
|
peptidylprolyl isomerase D
|
|
PPM1B
|
protein phosphatase, Mg2+/Mn2+ dependent, 1B
|
|
PPM1D
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
|
PPP1R3A
|
protein phosphatase 1, regulatory subunit 3A
|
|
PPP1R7
|
protein phosphatase 1, regulatory subunit 7
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PPP2R2B
|
protein phosphatase 2, regulatory subunit B, beta
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRDM2
|
PR domain containing 2, with ZNF domain
|
|
PRDM5
|
PR domain containing 5
|
|
PRDX6
|
peroxiredoxin 6
|
|
PREP
|
prolyl endopeptidase
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCDBP
|
protein kinase C, delta binding protein
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRNP
|
prion protein
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROX1
|
prospero homeobox 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGIS
|
prostaglandin I2 (prostacyclin) synthase
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK7
|
protein tyrosine kinase 7 (inactive)
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN13
|
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)
|
|
PTPN23
|
protein tyrosine phosphatase, non-receptor type 23
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PXN
|
paxillin
|
|
PYCARD
|
PYD and CARD domain containing
|
|
RAB32
|
RAB32, member RAS oncogene family
|
|
RAB6A
|
RAB6A, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
|
|
RACGAP1
|
Rac GTPase activating protein 1
|
|
RAD50
|
RAD50 homolog (S. cerevisiae)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAN
|
RAN, member RAS oncogene family
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RAP1B
|
RAP1B, member of RAS oncogene family
|
|
RAPGEF1
|
Rap guanine nucleotide exchange factor (GEF) 1
|
|
RARB
|
retinoic acid receptor, beta
|
|
RARRES1
|
retinoic acid receptor responder (tazarotene induced) 1
|
|
RASD1
|
RAS, dexamethasone-induced 1
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RASSF10
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 10
|
|
RASSF2
|
Ras association (RalGDS/AF-6) domain family member 2
|
|
RASSF5
|
Ras association (RalGDS/AF-6) domain family member 5
|
|
RB1
|
retinoblastoma 1
|
|
RBL2
|
retinoblastoma-like 2
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RELN
|
reelin
|
|
RET
|
ret proto-oncogene
|
|
RGMA
|
repulsive guidance molecule family member a
|
|
RHEB
|
Ras homolog enriched in brain
|
|
RHOA
|
ras homolog family member A
|
|
RHOJ
|
ras homolog family member J
|
|
RNF168
|
ring finger protein 168, E3 ubiquitin protein ligase
|
|
RNF43
|
ring finger protein 43
|
|
ROBO1
|
roundabout, axon guidance receptor, homolog 1 (Drosophila)
|
|
ROS1
|
ROS proto-oncogene 1 , receptor tyrosine kinase
|
|
RP2
|
retinitis pigmentosa 2 (X-linked recessive)
|
|
RPE65
|
retinal pigment epithelium-specific protein 65kDa
|
|
RPL22
|
ribosomal protein L22
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3
|
|
RPS6KA6
|
ribosomal protein S6 kinase, 90kDa, polypeptide 6
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RRAD
|
Ras-related associated with diabetes
|
|
RRAS
|
related RAS viral (r-ras) oncogene homolog
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RUNX3
|
runt-related transcription factor 3
|
|
S100B
|
S100 calcium binding protein B
|
|
SAE1
|
SUMO1 activating enzyme subunit 1
|
|
SAMD9L
|
sterile alpha motif domain containing 9-like
|
|
SAMHD1
|
SAM domain and HD domain 1
|
|
SARAF
|
store-operated calcium entry-associated regulatory factor
|
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase)
|
|
SCG5
|
secretogranin V
|
|
SCN10A
|
sodium channel, voltage gated, type X alpha subunit
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SCN1B
|
sodium channel, voltage gated, type I beta subunit
|
|
SCN3B
|
sodium channel, voltage gated, type III beta subunit
|
|
SCN4A
|
sodium channel, voltage gated, type IV alpha subunit
|
|
SCN4B
|
sodium channel, voltage gated, type IV beta subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
|
SDC4
|
syndecan 4
|
|
SDHA
|
succinate dehydrogenase complex, subunit A, flavoprotein (Fp)
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
|
SDHC
|
succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa
|
|
SELT
|
selenoprotein T
|
|
SEMA3B
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B
|
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F
|
|
SEMA5A
|
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A
|
|
SEPN1
|
selenoprotein N, 1
|
|
SERPIND1
|
serpin peptidase inhibitor, clade D (heparin cofactor), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF2
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2
|
|
SERPINH1
|
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1)
|
|
SET
|
SET nuclear proto-oncogene
|
|
SFN
|
stratifin
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SFRP2
|
secreted frizzled-related protein 2
|
|
SFTPA1
|
surfactant protein A1
|
|
SFTPD
|
surfactant protein D
|
|
SH3GL2
|
SH3-domain GRB2-like 2
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SHH
|
sonic hedgehog
|
|
SHOX
|
short stature homeobox
|
|
SIRT1
|
sirtuin 1
|
|
SIRT3
|
sirtuin 3
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC16A2
|
solute carrier family 16, member 2 (thyroid hormone transporter)
|
|
SLC22A4
|
solute carrier family 22 (organic cation/zwitterion transporter), member 4
|
|
SLC2A5
|
solute carrier family 2 (facilitated glucose/fructose transporter), member 5
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC8A1
|
solute carrier family 8 (sodium/calcium exchanger), member 1
|
|
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
|
|
SLIT2
|
slit homolog 2 (Drosophila)
|
|
SMAD1
|
SMAD family member 1
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMARCC1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOX1
|
SRY (sex determining region Y)-box 1
|
|
SOX4
|
SRY (sex determining region Y)-box 4
|
|
SOX7
|
SRY (sex determining region Y)-box 7
|
|
SP1
|
Sp1 transcription factor
|
|
SP3
|
Sp3 transcription factor
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPEN
|
spen family transcriptional repressor
|
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRD5A3
|
steroid 5 alpha-reductase 3
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
|
SRSF1
|
serine/arginine-rich splicing factor 1
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
ST3GAL1
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 1
|
|
ST7
|
suppression of tumorigenicity 7
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STIM1
|
stromal interaction molecule 1
|
|
STK11
|
serine/threonine kinase 11
|
|
STK38
|
serine/threonine kinase 38
|
|
STK4
|
serine/threonine kinase 4
|
|
SULF2
|
sulfatase 2
|
|
SULT1A3
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3
|
|
SULT1E1
|
sulfotransferase family 1E, estrogen-preferring, member 1
|
|
SULT2A1
|
sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1
|
|
SUV39H1
|
suppressor of variegation 3-9 homolog 1 (Drosophila)
|
|
SUZ12
|
SUZ12 polycomb repressive complex 2 subunit
|
|
SYT8
|
synaptotagmin VIII
|
|
TAC1
|
tachykinin, precursor 1
|
|
TACR1
|
tachykinin receptor 1
|
|
TACSTD2
|
tumor-associated calcium signal transducer 2
|
|
TADA3
|
transcriptional adaptor 3
|
|
TBP
|
TATA box binding protein
|
|
TCF4
|
transcription factor 4
|
|
TDP1
|
tyrosyl-DNA phosphodiesterase 1
|
|
TERT
|
telomerase reverse transcriptase
|
|
TES
|
testin LIM domain protein
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TFPI2
|
tissue factor pathway inhibitor 2
|
|
TFRC
|
transferrin receptor
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THBS1
|
thrombospondin 1
|
|
THBS2
|
thrombospondin 2
|
|
THBS4
|
thrombospondin 4
|
|
THRA
|
thyroid hormone receptor, alpha
|
|
THRB
|
thyroid hormone receptor, beta
|
|
THSD1
|
thrombospondin, type I, domain containing 1
|
|
TICAM1
|
toll-like receptor adaptor molecule 1
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TLE1
|
transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TLX1
|
T-cell leukemia homeobox 1
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF10C
|
tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TP53BP1
|
tumor protein p53 binding protein 1
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPP1
|
tripeptidyl peptidase I
|
|
TRAF3
|
TNF receptor-associated factor 3
|
|
TRIM37
|
tripartite motif containing 37
|
|
TRIP13
|
thyroid hormone receptor interactor 13
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TRPM2
|
transient receptor potential cation channel, subfamily M, member 2
|
|
TRPV5
|
transient receptor potential cation channel, subfamily V, member 5
|
|
TRPV6
|
transient receptor potential cation channel, subfamily V, member 6
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TTK
|
TTK protein kinase
|
|
TUSC2
|
tumor suppressor candidate 2
|
|
TUSC3
|
tumor suppressor candidate 3
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TWIST2
|
twist family bHLH transcription factor 2
|
|
UBA2
|
ubiquitin-like modifier activating enzyme 2
|
|
UBE2C
|
ubiquitin-conjugating enzyme E2C
|
|
UBE3A
|
ubiquitin protein ligase E3A
|
|
UBE4B
|
ubiquitination factor E4B
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UGT2B15
|
UDP glucuronosyltransferase 2 family, polypeptide B15
|
|
UGT2B17
|
UDP glucuronosyltransferase 2 family, polypeptide B17
|
|
UNC5C
|
unc-5 homolog C (C. elegans)
|
|
UOX
|
urate oxidase, pseudogene
|
|
UQCRH
|
ubiquinol-cytochrome c reductase hinge protein
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
WEE1
|
WEE1 G2 checkpoint kinase
|
|
WIF1
|
WNT inhibitory factor 1
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
WWP1
|
WW domain containing E3 ubiquitin protein ligase 1
|
|
XDH
|
xanthine dehydrogenase
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XIST
|
X inactive specific transcript (non-protein coding)
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XPO6
|
exportin 6
|
|
YAP1
|
Yes-associated protein 1
|
|
YWHAG
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
|
YY1
|
YY1 transcription factor
|
|
ZAK
|
sterile alpha motif and leucine zipper containing kinase AZK
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZIC1
|
Zic family member 1
|
|
ZMYND10
|
zinc finger, MYND-type containing 10
|
|
ZNF746
|
zinc finger protein 746
|
